Suchergebnisse - "Sun, Weina"

PubPharm (18)

1

Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination

enthalten in: Journal of virology | 2023

von Amanat, F. | Clark, J. | Carreño, J. | +9

2

An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination

enthalten in: Science translational medicine | 2023

von Carreño, J. | Raskin, A. | Singh, G. | +22

3

Group 1 and group 2 hemagglutinin stalk antibody response according to age

enthalten in: Frontiers in immunology | 2023

von Sánchez-de Prada, L. | Sanz-Muñoz, I. | Sun, W. | +5

4

Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants

enthalten in: Med (New York, N.Y.) | 2022

von Duty, J. | Kraus, T. | Zhou, H. | +46

5

Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice

enthalten in: Microbiology spectrum | 2022

von González-Domínguez, I. | Martínez, J. | Slamanig, S. | +14

UpdateOf: bioRxiv. 2022 Mar 22;:. - PMID 35350201

6

Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike : Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam

enthalten in: Vaccine | 2022

von Duc Dang, A. | Dinh Vu, T. | Hai Vu, H. | +30

7

A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice

enthalten in: Molecular therapy : the journal of the American Society of Gene Therapy | 2022

von Bliss, C. | Freyn, A. | Caniels, T. | +10

8

A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses

enthalten in: Nature communications | 2021

von Sun, W. | Liu, Y. | Amanat, F. | +22

9

Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs

enthalten in: mBio | 2021

von Lara-Puente, J. | Carreño, J. | Sun, W. | +16

10

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

enthalten in: Nature medicine | 2021

von Nachbagauer, R. | Feser, J. | Naficy, A. | +30